Skip to content
2000
Volume 16, Issue 5
  • ISSN: 1573-4137
  • E-ISSN: 1875-6786

Abstract

Ischemic stroke, which is the fifth leading cause of death, is an attack in the brain due to blockage of a brain artery. It occurs when a sudden loss of blood flow to the brain leads to a reduction in the oxygen supply. A wide range of reasons have been found for ischemic stroke, including high blood pressure and associated thrombosis. Suitable biomarker analysis followed by proper treatment helps to prevent ischemic stroke. An aptamer is an artificial antibody generated against various clinical biomarkers from a smaller molecule of a whole cell. Recently, several researchers conducted biomarker analysis for ischemic stroke using aptamers. Furthermore, factor IX, which is a blood clotting factor, is highly correlated with thrombosis and plays a role in ischemic stroke. In this review, we summarized the potential role of aptamers in ischemic stroke by nanoscale analysis, and factor IX was the distinct focus of this review.

Loading

Article metrics loading...

/content/journals/cnano/10.2174/1573413715666191111111718
2020-10-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/cnano/10.2174/1573413715666191111111718
Loading

  • Article Type:
    Review Article
Keyword(s): aptamer; biomarker; factor IX; Ischemic stroke; nanoscale analysis; thrombosis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test